MTF2 and sarcoma: In summary, the Kaplan–Meier analyses confirm published AML and hepatocellular carcinoma studies while underscoring potential prognostic or mechanistic roles of MTF2 in thymoma, uterine carcinosarcoma, and sarcoma.